Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitisCTS-CLINICAL AND TRANSLATIONAL SCIENCEIF2.82024-09-181OA
Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteersCTS-CLINICAL AND TRANSLATIONAL SCIENCEIF2.82024-03-152OAAI
Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patientsCELL REPORTS MEDICINEIF10.62022-04-019OAAI
Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01)EUROPEAN JOURNAL OF CANCERIF7.12016-05-0132PREAI
PROGNOSTIC FACTORS OF TUMOUR CELLULARITY IN IMAGE-GUIDED BIOPSIES: RESULTS FROM A PROSPECTIVE MOLECULAR TRIAGE TRIAL (MOSCATO)ANNALS OF ONCOLOGYIF65.42014-09-011OAAI
Role of FDG-PET in the Implementation of Involved-Node Radiation Therapy for Hodgkin Lymphoma PatientsINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52014-08-0135PREAI